|
|
|
|
|
1.
1143 Accesses
|
Extremely short duration high intensity interval training substantially improves insulin action in young healthy males
John A Babraj, Niels BJ Vollaard, Cameron Keast, Fergus M Guppy, Greg Cottrell, James A Timmons BMC Endocrine Disorders 2009, 9:3 (28 January 2009)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Low-volume, high-intensity exercise improves insulin action in sedentary males and may prove to be an efficient way of reducing risk factors for metabolic disease in those with little time for conventional high volume regimes.
|
|
|
2.
828 Accesses
|
Agrarian diet and diseases of affluence – Do evolutionary novel dietary lectins cause leptin resistance?
Tommy Jönsson, Stefan Olsson, Bo Ahrén, Thorkild C Bøg-Hansen, Anita Dole, Staffan Lindeberg BMC Endocrine Disorders 2005, 5:10 (10 December 2005)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
3.
587 Accesses
|
Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study
Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler, Katharina Schweitzer, Irene Virgolini, Roy Moncayo BMC Endocrine Disorders 2008, 8:15 (27 November 2008)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Levels of the thyroid hormones thyrotropin, thyroxine and triiodothyronine are highest in the month after birth and fall markedly during childhood and adolescence suggesting adult reference levels are inappropriate for use in the pediatric setting.
|
|
|
4.
583 Accesses
|
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
Jøran Hjelmesæth, Jo Røislien, Njord Nordstrand, Dag Hofsø, Helle Hager, Anders Hartmann BMC Endocrine Disorders 2010, 10:6 (18 April 2010)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Low serum creatinine is a predictor of type 2 diabetes in obese Caucasian patients, independent of hypertension and smoking, suggesting that further investigation is needed as to whether this may be causally linked with the condition
|
|
|
5.
527 Accesses
|
Self-care coping strategies in people with diabetes: a qualitative exploratory study
Margaret M Collins, Colin P Bradley, Tony O'Sullivan, Ivan J Perry BMC Endocrine Disorders 2009, 9:6 (20 February 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
6.
362 Accesses
|
The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis
M Hassan Murad, Ahmad Hazem, Fernando Coto-Yglesias, Svitlana Dzyubak, Shabnum Gupta, Irina Bancos, Melanie A Lane, Patricia J Erwin, Lars Berglund, Tarig Elraiyah, Victor M Montori BMC Endocrine Disorders 2012, 12:2 (31 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A meta-analysis of data from observational studies indicates that there is a strong association between fasting hypertriglyceridemia and an increased risk of cardiovascular events, although there is no significant association with all-cause mortality.
|
|
|
7.
315 Accesses
|
Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study
Conall M O'Seaghdha, Shih-Jen Hwang, Ramachandran S Vasan, Martin G Larson, Udo Hoffmann, Thomas J Wang, Caroline S Fox BMC Endocrine Disorders 2012, 12:3 (4 April 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Systemic activity of the Renin Angiotensin and Aldosterone System (RAAS) is not associated with increased regional adiposity, as assessed by computed tomography in a population-based study.
|
|
|
8.
299 Accesses
|
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
Debora Williams-Herman, Samuel S Engel, Elizabeth Round, Jeremy Johnson, Gregory T Golm, Hua Guo, Bret J Musser, Michael J Davies, Keith D Kaufman, Barry J Goldstein BMC Endocrine Disorders 2010, 10:7 (22 April 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
9.
289 Accesses
|
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
Rajib K Bhattacharya, Mohit Khera, Gary Blick, Harvey Kushner, Dat Nguyen, Martin M Miner BMC Endocrine Disorders 2011, 11:18 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
10.
249 Accesses
|
Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
Deepson S Shyangdan, Pamela L Royle, Christine Clar, Pawana Sharma, Norman R Waugh BMC Endocrine Disorders 2010, 10:20 (9 December 2010)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A new class of drugs, Glucagon-like peptide (GLP-1) analogues, improve glycemic control by suppressing glucagon secretion and stimulating insulin secretion and biosynthesis, as well as promoting weight loss.
|
|
|
11.
234 Accesses
|
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Debora Williams-Herman, Elizabeth Round, Arlene S Swern, Bret Musser, Michael J Davies, Peter P Stein, Keith D Kaufman, John M Amatruda BMC Endocrine Disorders 2008, 8:14 (27 October 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
12.
229 Accesses
|
Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran
Alireza Shamshirsaz, Mir Reza Bekheirnia, Mohammad Kamgar, Nima Pourzahedgilani, Navid Bouzari, Mohammadreza Habibzadeh, Reza Hashemi, Amirhooshang Shamshirsaz, Shahriar Aghakhani, Hooman Homayoun, Bagher Larijani BMC Endocrine Disorders 2003, 3:4 (12 August 2003)
Abstract | Full text | PDF | PubMed
|
|
|
13.
227 Accesses
|
Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
Anna M Sawka, Lehana Thabane, Amiram Gafni, Mitchell Levine, William F Young BMC Endocrine Disorders 2005, 5:1 (28 February 2005)
Abstract | Full text | PDF | PubMed
|
|
|
14.
226 Accesses
|
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, Reidar Fossmark, Jan H Waarsing, Erik F Eriksen, Christiane Petzold, Janne E Reseland, Unni Syversen BMC Endocrine Disorders 2011, 11:11 (26 May 2011)
Abstract | Full text | PDF | PubMed
|
|
|
15.
214 Accesses
|
Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study
Charlotte A Larsson, Bo Gullberg, Lennart Råstam, Ulf Lindblad BMC Endocrine Disorders 2009, 9:16 (21 June 2009)
Abstract | Full text | PDF | PubMed
|
|
|
16.
212 Accesses
|
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Beverly MK Biller, Annamaria Colao, Stephan Petersenn, Vivien S Bonert, Marco Boscaro BMC Endocrine Disorders 2010, 10:10 (17 May 2010)
Abstract | Full text | PDF | PubMed
|
|
|
17.
191 Accesses
|
Post-partum pituitary insufficiency and livedo reticularis presenting a diagnostic challenge in a resource limited setting in Tanzania: a case report, clinical discussion and brief review of existing literature
Faheem G Sheriff, William P Howlett, Kajiru G Kilonzo BMC Endocrine Disorders 2012, 12:4 (14 May 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
18.
190 Accesses
|
Thyroid function derangement and childhood obesity: an Italian experience
Anna Grandone, Nicola Santoro, Filomena Coppola, Paolo Calabrò, Laura Perrone, Emanuele del Giudice BMC Endocrine Disorders 2010, 10:8 (4 May 2010)
Abstract | Full text | PDF | PubMed
|
|
|
19.
183 Accesses
|
The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma
Roy Moncayo, Alexander Kroiss, Manfred Oberwinkler, Fatih Karakolcu, Matthias Starzinger, Klaus Kapelari, Heribert Talasz, Helga Moncayo BMC Endocrine Disorders 2008, 8:2 (25 January 2008)
Abstract | Full text | PDF | PubMed
|
|
|
20.
179 Accesses
|
Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial
Jeroen Lakerveld, Sandra DM Bot, Marijke J Chinapaw, Maurits W van Tulder, Patricia van Oppen, Jacqueline M Dekker, Giel Nijpels BMC Endocrine Disorders 2008, 8:6 (24 June 2008)
Abstract | Full text | PDF | PubMed
|
|
|
21.
175 Accesses
|
Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection
Bagher Larijani, Mohammad Pajouhi, Hossein Ghanaati, Mohammad-Hassan Bastanhagh, Fereshteh Abbasvandi, Kazem Firooznia, Mahmood Shirzad, Mohammad-Reza Amini, Maryam Sarai, Nasreen Abbasvandi, Reza Baradar-Jalili BMC Endocrine Disorders 2002, 2:3 (6 December 2002)
Abstract | Full text | PDF | PubMed
|
|
|
22.
170 Accesses
|
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes
Alan J Sinclair, Charles M Alexander, Michael J Davies, Changgeng Zhao, Panagiotis Mavros BMC Endocrine Disorders 2012, 12:1 (7 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
In a UK cohort, antihyperglycaemic medication was initiated in 51% of patients newly diagnosed with type 2 diabetes mellitus (T2DM) within a 2 year period following diagnosis, elevated HbA1c was the strongest factor associated with initiation of medication.
|
|
|
23.
168 Accesses
|
Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity
Pernille Keller, Valentina Gburcik, Natasa Petrovic, Iain J Gallagher, Jan Nedergaard, Barbara Cannon, James A Timmons BMC Endocrine Disorders 2011, 11:7 (22 March 2011)
Abstract | Full text | PDF | PubMed |
|
|
|
24.
156 Accesses
|
Short term effects of a low-carbohydrate diet in overweight and obese subjects with low HDL-C levels
Ahmet Can, Canan Uysal, K Erhan Palaoğlu BMC Endocrine Disorders 2010, 10:18 (9 November 2010)
Abstract | Full text | PDF | PubMed
|
|
|
25.
148 Accesses
|
Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial
Sakineh Shab-Bidar, Tirang R Neyestani, Abolghassem Djazayery BMC Endocrine Disorders 2011, 11:12 (22 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|